Healthcare

Federal clearance of Moderna and Johnson & Johnson Covid-19 boosters, and signoff on mixing and matching doses, add complexity to an already struggling government messaging campaign—but the advice may be simpler than it appears.

Healthcare prices have grown more slowly than economywide prices since mid-summer, a trend economists describe in a new report as "quite extraordinary."

Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines are expected to soon be lining up for another dose. 

RALEIGH, N.C. — This year in North Carolina, 15 law enforcement officers have had line-of-duty deaths. Ten of them were from COVID-19.

The National Hockey League will open its season Oct. 12. As of Oct. 1, just 12 NHL players were reported to not be fully vaccinated, though several are reported to be in line to have their second dose by opening night. This means that no less than 20 teams are fully vaccinated.

When Sheila Mahoney got a text alert that she may have been exposed to the coronavirus, the Baltimore resident spent an hour on the state’s online testing locator and then directly on pharmacy websites, finding one next-day appointment — in Virginia.

The covid-19 booster shot debate is now in full gear. Ongoing review, analysis and discussions involving the FDA, the CDC and the White House are bringing more chaos into a public health environment that needs calm and consistency, not confusion.

Doctors warn that this flu season could be particularly severe, renewing fears of a potential “twindemic” in which the spread of that virus and COVID-19 collide.

The Biden administration’s COVID-19 booster shot campaign is off to a promising start, with about 1 million Americans signed up to receive a third Pfizer dose at pharmacies in the coming weeks, and adverse reactions to booster shots are rare, according to new Centers for Disease Control and Prevention data released Tuesday.

URBANA, Illinois -- The federal Centers for Disease Control and Prevention (CDC) provides weekly reports on breakthrough infections leading to hospitalizations and deaths. However, similar data on infections amongst previously infected people are needed to assess the road to the virus becoming endemic -- present in the population but manageable due to widespread immunity.